OR Royalties Inc. OR.TO TSX · Basic materials · Canada
$43.51 -3.61% -$1.63
Summary
70 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 21% a year over the last 3 years.
- Out of every 100 USD of revenue, 67 USD is left as net profit.
- It earns 13 USD a year on every 100 USD of invested capital.
- Analysts expect revenue to grow by 95% this fiscal year.
What to watch
- It reports a profit, yet spends more cash than it brings in.
- Earnings per share swing sharply from year to year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedBy our assumptions the price matches the value of the business: the two differ by less than 10 %.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 22.9 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 11% a year over 5 years. Over the last 3 years it grew by 20% a year. For the next fiscal year analysts expect revenue to grow by 95%. Earnings per share grew by 21% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 15 USD
- Research and development 0.5 USD
- Sales and administration 7.3 USD
- Taxes and other 9.9 USD
- Net profit 67 USD
Net profit, industry median (Gold) 29 USD
Out of every 100 USD of revenue, 67 USD is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenOver the last 12 months it spent more cash than it brought in. Its debt is larger than its cash. The debt score is high even though free cash flow is negative.
Financial health in detailDoes it pay a dividend?
Small, at risk- Yield
- 0.41%
- Paid out of profit
- 9.4%
You receive $0.18 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 5
- Hold 4
- Sell 0
No analyst has published a price target.
56% of the analysts recommend buying.
Analysts in detail